Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 32.67
(0.28%)
CNY 32.67
(0.28%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.03 Million CNY | -60.25% |
| 2022 | 7.64 Million CNY | -38.7% |
| 2021 | 12.47 Million CNY | 12.46% |
| 2020 | 11.08 Million CNY | -65.48% |
| 2019 | 32.12 Million CNY | 59.89% |
| 2018 | 20.09 Million CNY | -0.19% |
| 2017 | 20.13 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 744.3 Thousand CNY | -81.89% |
| 2024 Q1 | 2.13 Million CNY | -29.62% |
| 2024 Q2 | 1.65 Million CNY | -22.81% |
| 2023 Q4 | 3.03 Million CNY | -8.75% |
| 2023 FY | 3.03 Million CNY | -60.25% |
| 2023 Q3 | 3.33 Million CNY | -35.91% |
| 2023 Q2 | 5.19 Million CNY | -27.72% |
| 2023 Q1 | 7.18 Million CNY | -5.97% |
| 2022 Q3 | 6 Million CNY | -3.23% |
| 2022 Q2 | 6.2 Million CNY | -6.42% |
| 2022 Q1 | 6.62 Million CNY | -46.84% |
| 2022 FY | 7.64 Million CNY | -38.7% |
| 2022 Q4 | 7.64 Million CNY | 27.35% |
| 2021 Q3 | 21.85 Million CNY | 54.86% |
| 2021 FY | 12.47 Million CNY | 12.46% |
| 2021 Q4 | 12.47 Million CNY | -42.93% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q2 | 14.11 Million CNY | 0.0% |
| 2020 Q4 | 11.08 Million CNY | 0.0% |
| 2020 Q2 | 4.31 Million CNY | 0.0% |
| 2020 FY | 11.08 Million CNY | -65.48% |
| 2020 Q1 | 4.31 Million CNY | 0.0% |
| 2019 FY | 32.12 Million CNY | 59.89% |
| 2018 FY | 20.09 Million CNY | -0.19% |
| 2017 FY | 20.13 Million CNY | 0.0% |